The objective was to investigate the effects of valsartan on the electrophysiological
characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive …

Background It has been shown by various diagnostic methodologies that angiotensin
receptor blockage reduces left ventricular mass, improves diastolic function and increases …

This study evaluated the effect of sacubtril/valsartan on cardiac remodeling, molecular and
cellular adaptations in experimental (rat) model of hypertension-induced hypertrophic …

Objective To determine the protein expression of Calpain I, mRNA and protein expressions
and activity of calcineurin, and the alternative splicing of Ca/calmodulin-dependent protein …

Background: Left ventricular hypertrophy (LVH) is an endpoint of hypertensive cardiac
alterations. Renin-angiotensin-aldosterone system (RAAS) blockers are among the most …

The present study aimed to determine the effect of chronic treatment with losartan on
transient outward potassium current (Ito) and the expression levels of potassium voltage …

AIM: To evaluate the antihypertensive efficacy of angiotensin converting enzyme inhibitor
(ACEI) benazepril in combination with AT1 receptor antagonist valsartan and their effect on …

Background: Sacubitril/valsartan was shown to attenuate the development of cardiac
hypertrophy with enhanced blood pressure reduction compared with valsartan alone in …

It is not clear how the blocking effect of angiotensin II receptors by olmesartan affects the
functional recovery of pressure-overload hypertrophied heart. Hypertrophied heart was …

Olmesartan Medoxomil (OM) on left ventricle hypertrophy (LVH) and inflammatory cytokines
IL-6 and IL-10 levels in renovascular hypertensive rats. MATERIALS AND METHODS …